Schedule 13G ownership disclosure
MARINUS PHARMACEUTICALS INC
Security class unavailable · CUSIP: 56854Q200
Event date: 2023-09-29
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 5.5300%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000929638-23-002740
- Form type
- SC 13G
- Filer
- Cormorant Asset Management, LP
- CIK
- CIK 1583977
- Filed
- Oct 10, 2023
- Reporting period
- Sep 29, 2023
- Description
- Schedule 13G beneficial ownership